NUS — NU Skin Enterprises Share Price
Last trade - 00:00- $440.76m
- $465.97m
- $1.73bn
- 91
- 91
- 73
- 98
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 10.26 | ||
| PEG Ratio (f) | 0.17 | ||
| EPS Growth (f) | 143.61% | ||
| Dividend Yield (f) | 2.69% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.58 | ||
| Price to Tang. Book | 0.71 | ||
| Price to Free Cashflow | 6.69 | ||
| Price to Sales | 0.26 | ||
| EV to EBITDA | 6.52 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 0.52% | ||
| Return on Equity | -4.93% | ||
| Operating Margin | 0.35% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 2,581.93 | 2,695.67 | 2,225.66 | 1,969.13 | 1,732.08 | 1,482.92 | 1,272.27 | -6.47% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +16.86 | -3.42 | -22.98 | -84.05 | n/a | n/a | -24.29 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Nu Skin Enterprises Inc. develops and distributes a comprehensive line of beauty and wellness solutions in approximately 50 markets worldwide. It has nine segments, consisting of its seven geographic Nu Skin segments - Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan - and two Rhyz segments - Manufacturing and Rhyz Other. Its brands include Nu Skin personal care, Pharmanex nutrition and ageLOC anti-aging. Its skin and beauty solutions include acne and blemishes, anti-aging, dark circles and puffiness, discoloration, dry skin, lifting and firming, lines and wrinkles, and oily skin and pores. Its nutrition solutions include bone and joint health, brain and memory, energy and stamina, heart health, immunity support, nail skin and hair health, and women's health. It offers various beauty devices, including ageLOC Rose Gold LumiSpa iO, ageLOC LumiSpa Silicone Head, ageLOC LumiSpa iO Stand and LumiSpa Rose Gold Accent Twin Pack.
Directors
- Steven Lund CHM (67)
- Ryan Napierski PRE (47)
- Mark Lawrence CFO (51)
- Joseph Chang EVP (68)
- Chayce Clark EVP
- Connie Tang EVP
- Daniel Campbell LED (66)
- Emma Battle DRC (61)
- Andrew Lipman IND (69)
- Laura Nathanson IND (63)
- Thomas Pisano IND (76)
- Zheqing Shen IND (41)
- Edwina Woodbury IND (69)
- Last Annual
- December 31st, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- September 4th, 1996
- Public Since
- November 22nd, 1996
- No. of Shareholders
- 207
- No. of Employees
- 3,100
- Sector
- Personal & Household Products & Services
- Industry
- Consumer Defensives
- Exchange
- New York Stock Exchange
- Shares in Issue
- 49,412,994
- Address
- ATTN: D. MATTHEW DORNY, PROVO, 84601
- Web
- https://www.nuskin.com/
- Phone
- +1 8013456100
- Auditors
- PricewaterhouseCoopers LLP
Latest News for NUS
Upcoming Events for NUS
Q2 2025 NU Skin Enterprises Inc Earnings Release
Q3 2025 NU Skin Enterprises Inc Earnings Release
Similar to NUS
Adtalem Global Education
New York Stock Exchange
Bright Horizons Family Solutions
New York Stock Exchange
Bright Scholar Education Holdings
New York Stock Exchange
Carriage Services
New York Stock Exchange
Church & Dwight Co
New York Stock Exchange
FAQ
As of Today at 22:23 UTC, shares in NU Skin Enterprises are trading at $8.92. This share price information is delayed by 15 minutes.
Shares in NU Skin Enterprises last closed at $8.92 and the price had moved by -18.69% over the past 365 days. In terms of relative price strength the NU Skin Enterprises share price has underperformed the S&P500 Index by -27.31% over the past year.
The overall consensus recommendation for NU Skin Enterprises is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe NU Skin Enterprises dividend yield is 2.69% based on the trailing twelve month period.
Last year, NU Skin Enterprises paid a total dividend of $0.24, and it currently has a trailing dividend yield of 2.69%. We do not have any data on when NU Skin Enterprises is to next pay dividends.
We do not have data on when NU Skin Enterprises is to next pay dividends. The historic dividend yield on NU Skin Enterprises shares is currently 2.69%.
To buy shares in NU Skin Enterprises you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $8.92, shares in NU Skin Enterprises had a market capitalisation of $440.76m.
Here are the trading details for NU Skin Enterprises:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: NUS
Based on an overall assessment of its quality, value and momentum NU Skin Enterprises is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in NU Skin Enterprises is $7.50. That is 15.92% below the last closing price of $8.92.
Analysts covering NU Skin Enterprises currently have a consensus Earnings Per Share (EPS) forecast of $0.99 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like NU Skin Enterprises. Over the past six months, its share price has outperformed the S&P500 Index by +13.67%.
As of the last closing price of $8.92, shares in NU Skin Enterprises were trading +25.89% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The NU Skin Enterprises PE ratio based on its reported earnings over the past 12 months is 10.26. The shares last closed at $8.92.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
NU Skin Enterprises' management team is headed by:
- Steven Lund - CHM
- Ryan Napierski - PRE
- Mark Lawrence - CFO
- Joseph Chang - EVP
- Chayce Clark - EVP
- Connie Tang - EVP
- Daniel Campbell - LED
- Emma Battle - DRC
- Andrew Lipman - IND
- Laura Nathanson - IND
- Thomas Pisano - IND
- Zheqing Shen - IND
- Edwina Woodbury - IND